AVITA Medical (RCEL) Depreciation & Amortization (CF) (2019 - 2026)

AVITA Medical (RCEL) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $700000.0 in Q4 2025.

• Quarterly Depreciation & Amortization (CF) rose 71.15% year-over-year to $700000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (up 108.44% YoY) and the FY2025 annual result came in at $2.3 million, up 108.44% from the prior year.
• Depreciation & Amortization (CF) improved to $700000.0 in Q4 2025, from $574000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $700000.0 in Q4 2025 to a low of -$242000.0 in Q4 2022.
• A 5-year average of $287944.4 and a median of $203500.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) tumbled 74.85% — and 2023, when it surged 177.27%.
• Tracing RCEL's Depreciation & Amortization (CF) over 5 years: stood at $517000.0 in 2021, then plunged by 146.81% to -$242000.0 in 2022, then surged by 177.27% to $187000.0 in 2023, then soared by 118.72% to $409000.0 in 2024, then jumped by 71.15% to $700000.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $700000.0 (Q4 2025), $574000.0 (Q3 2025), and $552000.0 (Q2 2025), per Business Quant data.